HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Difference of Treatment Results between Botulinum Toxin A Split Injection Sites and Botulinum Toxin A Non-Split Injection Sites for Hemifacial Spasm.

AbstractOBJECTIVE:
To compare hemifacial spasm treatment results between Botulinum toxin A split injection sites and Botulinum toxin A non-split injection sites.
MATERIAL AND METHOD:
Thirty-one hemifacial spasm patients were randomly assigned into the non-split injection sites group (injecting Botulinum toxin A to the zygomaticus major and risorius each) or split injection sites group with the same amount of Botulinum toxin A as the first method (injection Botulinum toxin A to the zygomaticus major and minor and risorius two injections each) The main outcomes are onset of improvement and effective duration of treatment.
RESULTS:
Fifteen patients were assigned to non-split injection sites group and 16 patients were assigned to split injection sites group. The median onset of improvement in non-split injection sites group and split injection sites group was 4.0 and 4.5 days, respectively (p = 0.984). The effective duration of treatment in the non-split injection sites group was 60.0 days and in the split injection sites group was 54.5 days (p = 0.582).
CONCLUSION:
The splitting of injection sites did not signicantly improve the efficacy of Botulinum toxin A in the treatment of hemifacial spasm.
AuthorsAnuwat Prutthipongsit, Nipat Aui-aree
JournalJournal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai) Vol. 98 Issue 11 Pg. 1119-23 (Nov 2015) ISSN: 0125-2208 [Print] Thailand
PMID26817183 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Botulinum Toxins, Type A
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Botulinum Toxins, Type A (therapeutic use)
  • Double-Blind Method
  • Female
  • Hemifacial Spasm (drug therapy)
  • Humans
  • Injections, Intramuscular
  • Male
  • Middle Aged
  • Prospective Studies
  • Thailand
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: